Robotic Biopsy Devices Market is expected to register 9.4% CAGR over the forecast period 2022 to 2032 - Future Market Insights

News provided by

Aug 10, 2022, 07:30 ET

Burgeoning Demand for Minimally Invasive Procedures to Provide Robotic Biopsy Devices US$ 1.1 Bn Market Opportunity by 2032. Europe robotic biopsy devices market is expected to register growth at a CAGR of around 8.6% over the next ten years

NEWARK, Del., Aug. 10, 2022 /PRNewswire/ -- As per Future Market Insights' latest industry analysis, the global robotic biopsy devices market was valued at around US$ 386.4 Mn in 2021 and is projected to exhibit a CAGR of 9.4% over the forecast period. The market is set to reach US$ 435.6 Mn in 2022 and US$ 1.1 Bn in 2032.

One of the most significant cutting-edge technologies in neurosurgery is robot-assisted biopsy for brain tumors. Robot-assisted biopsy is used to increase the safety and effectiveness of biopsy technique, which is highly desired when organizing the management of tumor pathology.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15412

The main objective of this cutting-edge technology is to add safety equipment to the modern neurosurgery operative inventory so that it can methodically improve the precision and accuracy in operation theaters, which is not otherwise conceivable. Additionally, robotic biopsy makes the thorough preoperative process easier than other types.

The market for robotic biopsy devices is anticipated to grow at a fast pace over the projected years due to rising need for safe and effective minimally invasive procedures and growing use of automated systems in the healthcare sector. It can be further attributed to rapid transformation of conventional healthcare systems to integrated digital technology.

Key Takeaways: Robotic Biopsy Devices Market

By product, the systems segment is expected to showcase high growth at a CAGR of 4% by the end of 2032.
By application, the brain biopsy category is leading the global robotic biopsy devices market and is projected to exhibit a CAGR of 3% during the forecast period.
By end user, hospitals held around 5% of the global robotic biopsy devices market share in 2021.
The U.S. currently dominates the North America robotic biopsy devices market and it had generated a share of about 8% in 2021.
The U.K. is set to hold a share of nearly 2% in the global robotic biopsy devices market during the assessment period.

"Increasing use of automated technologies for surgical procedures and growing global burden of chronic diseases are expected to drive sales of robotic biopsy devices," says an analyst of Future Market Insights.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15412

Competition Landscape: Robotic Biopsy Devices Market

The market for robotic biopsy devices is oligopolistic, with the presence of a few established manufacturers. Product range of every player in the market varies as per the competitors' licensed novel devices with unique applications. Key players are striving to gain regulatory authorizations for creating new medical devices, generating high product sales, and initiating marketing purposes.

In October 2021, Medtronic reported that the Hugo robotic-assisted surgery (RAS) system had been granted the CE (Conformité Européenne) Mark, allowing for sales of the system across Europe.

What Does the Robotic Biopsy Devices Market Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the robotic biopsy devices market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032.

The research study is based on the product (systems and instrument & accessories), application (lung biopsy, brain biopsy, prostate biopsy, and others), and end user (hospitals, ambulatory surgical centers, and academic & research institutes) across seven key regions of the world.

Buy Now@ https://www.futuremarketinsights.com/checkout/15412

Robotic Biopsy Devices Market Outlook by Category

By Product:

Systems
Instrument & Accessories

By Application:

Brain Biopsy
Lung Biopsy
Prostate biopsy
Others

By End User:

Hospitals
Ambulatory Surgical Centers
Academic & Research Institutes

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15412

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions & Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Growing Incidence of Cancer

4.2. Product and Technology Assessment

4.3. Regulatory Landscape

4.4. Reimbursement Scenario

5. Market Background

5.1. Macro-Economic Factors

5.2. Forecast Factors - Relevance & Impact

TOC continued..!

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business.

Have a Look at Healthcare Domain Related Research Reports:

Portable Medical Devices Market Size - The overall Portable Medical Devices market is projected to expand at a CAGR of 10.7% during the forecast period.

Liquid Biopsy Market Share - As per a recent market analysis by ESOMAR-certified firm Future Market Insights (FMI), the global Liquid Biopsy Market value is pegged to reach US$ 1,026 Mn in 2021. Rising at 13.49% CAGR the market is expected to total US$ 3,637 Mn by 2031.

Breast Biopsy Market Trends - Breast biopsy is a diagnostic procedure used involves the removal of sample from breast tissue for laboratory testing to determine the presence of cancerous cells. Biopsy is an initial test suggesting the area of tissue in the body not seems to be normal.

Aspiration & Biopsy Needles Market Growth - The sales of global Aspiration and Biopsy Needles Market are estimated to reach US$ 1.29 Bn by 2026, registering a growth of 7% over the forecast period 2022 to 2032.

Robotic X-ray Scanner Market Analysis - Robotic X-ray scanner is a medical imaging device which gives flexibility to the medical practitioner. It has got its name from its characteristic of moving according to commands given to it.

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/robotic-biopsy-devices-market
LinkedIn| Twitter| Blogs